Literature DB >> 9283597

Comparative genomic hybridization analysis of human neuroblastomas: detection of distal 1p deletions and further molecular genetic characterization of neuroblastoma cell lines.

N Van Roy1, A Jauch, M Van Gele, G Laureys, R Versteeg, A De Paepe, T Cremer, F Speleman.   

Abstract

Deletions of the short arm of chromosome 1 and MYCN amplification are the most frequently encountered genetic changes in disseminated neuroblastomas and neuroblastoma cell lines. Different strategies have been followed for detection of these and other genomic changes in neuroblastoma including karyotyping, FISH, and LOH, each with its own limitations. Here we report upon the evaluation of comparative genomic hybridization (CGH) in the analysis of neuroblastoma cell lines, with the emphasis on the assessment of the reliability of CGH for the detection of distal 1p deletions. We have analyzed seven neuroblastoma cell lines for which the 1p status was previously studied in detail using FISH and LOH. Our results show that CGH allows reliable detection of distal 1p deletions, including a small interstitial deletion in cell line SK-N-AS. Furthermore, CGH also allows the detection of chromosomal imbalance which would otherwise remain undetected, and provides useful information for further molecular characterization of chromosomal imbalances.

Entities:  

Mesh:

Year:  1997        PMID: 9283597     DOI: 10.1016/s0165-4608(96)00362-7

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  7 in total

1.  Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36.

Authors:  M Gibbs; J L Stanford; R A McIndoe; G P Jarvik; S Kolb; E L Goode; L Chakrabarti; E F Schuster; V A Buckley; E L Miller; S Brandzel; S Li; L Hood; E A Ostrander
Journal:  Am J Hum Genet       Date:  1999-03       Impact factor: 11.025

2.  Duplication of a genomic region containing the Cdc2L1-2 and MMP21-22 genes on human chromosome 1p36.3 and their linkage to D1Z2.

Authors:  R Gururajan; J M Lahti; J Grenet; J Easton; I Gruber; P F Ambros; V J Kidd
Journal:  Genome Res       Date:  1998-09       Impact factor: 9.043

3.  Region-specific detection of neuroblastoma loss of heterozygosity at multiple loci simultaneously using a SNP-based tag-array platform.

Authors:  John M Maris; George Hii; Craig A Gelfand; Shobha Varde; Peter S White; Eric Rappaport; Saul Surrey; Paolo Fortina
Journal:  Genome Res       Date:  2005-08       Impact factor: 9.043

4.  Characterization of two ectrodactyly-associated translocation breakpoints separated by 2.5 Mb on chromosome 2q14.1-q14.2.

Authors:  Dezso David; Bárbara Marques; Cristina Ferreira; Paula Vieira; Alfredo Corona-Rivera; José Carlos Ferreira; Hans van Bokhoven
Journal:  Eur J Hum Genet       Date:  2009-02-18       Impact factor: 4.246

5.  Novel agents targeting the IGF-1R/PI3K pathway impair cell proliferation and survival in subsets of medulloblastoma and neuroblastoma.

Authors:  Anna Wojtalla; Fabiana Salm; Ditte G Christiansen; Tiziana Cremona; Paulina Cwiek; Tarek Shalaby; Nicole Gross; Michael A Grotzer; Alexandre Arcaro
Journal:  PLoS One       Date:  2012-10-08       Impact factor: 3.240

6.  Combined subtractive cDNA cloning and array CGH: an efficient approach for identification of overexpressed genes in DNA amplicons.

Authors:  Katleen De Preter; Filip Pattyn; Geert Berx; Kristin Strumane; Björn Menten; Frans Van Roy; Anne De Paepe; Frank Speleman; Jo Vandesompele
Journal:  BMC Genomics       Date:  2004-02-03       Impact factor: 3.969

7.  No evidence for involvement of SDHD in neuroblastoma pathogenesis.

Authors:  Katleen De Preter; Jo Vandesompele; Jasmien Hoebeeck; Caroline Vandenbroecke; Jöel Smet; Annick Nuyts; Geneviève Laureys; Valérie Combaret; Nadine Van Roy; Frank Roels; Rudy Van Coster; Marleen Praet; Anne De Paepe; Frank Speleman
Journal:  BMC Cancer       Date:  2004-08-24       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.